Veterinary Medicines

Rabisin suspensija injekcijām liellopiem, zirgiem, aitām, suņiem, kaķiem un mājas seskiem

Authorised
  • Rabies virus, Inactivated
Download as PDF

Product identification

Medicine name:
Rabisin suspensija injekcijām liellopiem, zirgiem, aitām, suņiem, kaķiem un mājas seskiem
Active substance:
  • Rabies virus, Inactivated
Target species:
  • Cattle
  • Sheep
  • Dog
  • Cat
  • Ferret
  • Horse
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Rabies virus, strain G52, Inactivated
    1.00
    international unit(s)
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Not specified
        0
        day
    • Sheep
      • Not specified
        0
        day
    • Dog
    • Cat
    • Ferret
  • Intramuscular use
    • Horse
      • Not specified
        0
        day
    • Cattle
      • Not specified
        0
        day
    • Sheep
      • Not specified
        0
        day
    • Dog
    • Cat
    • Ferret
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia

Additional information

Entitlement type:
  • Parallel Trade Approval
Marketing authorisation date:
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/I/23/0004
Parallel trade in reference of:
Parallel trade of:
Source wholesaler:
  • Hurtownia Lekow Weterynaryjnych Weterpol Sp. z o.o.
Destination wholesaler:
  • Magnum Veterinarija SIA
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."